Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference ⊕
found
⊕ Slightly Positive overall
0.00 negativity
0.92 neutrality
0.08 positivity
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.